Concepedia

Chester L. Bowen

CL

Statistics

Publications

17

Citations

708

H-Index

13

Active since

2007

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Chester L. Bowen is an author at GlaxoSmithKline (United States) specializing in pharmacy, pharmaceutical analysis, and mass spectrometric analysis.

ORCID

Publications per year

2007–2018

17

Publications

17

Direct analysis of dried blood spots utilizing desorption electrospray ionization (DESI) mass spectrometry

Justin M. Wiseman, Christopher A. Evans, Chester L. Bowen et al. · The Analyst · 2010 · 137 citations

, , +17

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours

Sarah P. Blagden, L. Rhoda Molife, A Seebaran et al. · British Journal of Cancer · 2008 · 82 citations · Full text

, , +12

Development of a sensitive and selective LC–MS/MS method for simultaneous determination of gemcitabine and 2,2-difluoro-2-deoxyuridine in human plasma

Chester L. Bowen, Sherry S. Wang, Hermes Licea‐Perez · Journal of Chromatography B · 2009 · 59 citations

, , +12

Development of a sensitive and selective LC-MS/MS method for the determination of α-fluoro-β-alanine, 5-fluorouracil and capecitabine in human plasma

Hermes Licea‐Perez, Sherry S. Wang, Chester L. Bowen · Journal of Chromatography B · 2009 · 55 citations

, , +8

A Novel Approach to Capillary Plasma Microsampling for Quantitative Bioanalysis

Chester L. Bowen, Hermes Licea‐Perez, Molly Z Karlinsey et al. · Bioanalysis · 2013 · 55 citations

, , +12

1–5 of 17